Risk factor
Poor trading liquidity
Profitability factor
Very strong margins and returns
About
Indegene Limited operates as a life sciences commercialization company in India and internationally. It helps biopharmaceutical, emerging biotech, and medical device companies develop products, get to the market, and grow impact through the life cycle. The company offers enterprise commercial solutions, enterprise medical solutions, enterprise clinical solutions, omnichannel activation solutions, and NEXT technology platforms. The...
Company Valuation
Considering past and projected metrics, the stock is neither 'expensive' nor 'cheap' compared to its peers. Specifically, the stock is fairly valued on P/E, neutral on EV
Target Price
The average target price of INDGN.BO is 616 and suggests 30% upside potential. Usually, this means a BUY recommendation among investment firms, or a recommendation to inc
Buy
Sell